|
|
||||||||



* Immune Regulation Group, Centenary Institute of Cancer Medicine and Cell Biology, Sydney, Australia; and
University of Sydney, Sydney, Australia
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Immunological memory is characterized by a rapid and robust response after re-exposure to the original immunizing Ag (5), such that 10- to 100-fold more Ag-specific B cells become detectable in spleen and bone marrow of responding individuals, compared with the increase in naive B cells after primary exposure (14, 15). A number of different mechanisms have been proposed to explain this observation. The unique positioning of memory B cells in Ag-draining sites of secondary lymphoid tissue such as splenic MZ and tonsil mucosal epithelium, as well as enhanced expression of costimulatory molecules, may facilitate rapid presentation of Ag to specific T cells, which in turn would promote robust secondary humoral responses (1, 3, 10, 11, 16). More recently, work in a B cell receptor (BCR) transgenic system has led to the proposition that the cytoplasmic domain of surface IgG serves as the molecular determinant responsible for the characteristically heightened reactivity of memory B cells over naive B cells (17). This effect was manifested by enhanced survival of activated B cells, rather than by recruitment of a greater number of cells into the response or an increase in their rate of expansion (17). Thus, a number of intrinsic and extrinsic features of memory B cells appear to contribute to rapid secondary immune responses.
We have previously reported that a greater number of cells is generated from cultures of human memory B cells compared with naive B cells after in vitro culture with CD40 ligand (CD40L) alone or in the presence of IL-2 and/or IL-10 (51). Furthermore, the proportion of memory B cells that entered division always exceeded that of naive B cells. These experiments suggested that intrinsic differences in proliferative behavior of naive and memory B cells may contribute to enhanced responses of memory B cells in vivo. We have now studied the proliferative behavior of naive and memory B cells in greater detail with a view to explaining the difference in responsiveness of these cells. Memory B cells entered division 2030 h earlier than did naive B cells. Furthermore, although IL-10 enhanced proliferation of both CD40L-stimulated naive and memory B cells, IL-2 selectively promoted the expansion of memory B cells. Importantly, only memory B cells differentiated into CD38+ effector cells, which acquired a unique proliferative behavior such that their rate of division exceeded that of CD38- memory B cell blasts and naive B cells by up to 2-fold. Thus, memory B cells possess an intrinsic advantage over naive B cells in both the time to initiate a response and the rate of generating rapidly dividing effector cells. These differences help explain the accelerated Ab response exhibited by memory B cells after secondary challenge by an invading pathogen, a hallmark of immunological memory.
| Materials and Methods |
|---|
|
|
|---|
Streptavidin conjugated to TriColor (SA-TC) and PE-conjugated
and biotinylated anti-CD38 mAb were purchased from Caltag
(Burlingame, CA). PE-conjugated anti-CD25, CD27, CD132 (IL-2R
),
anti-5-bromo-2'-deoxyuridine (BrdU) mAb, isotype control mAb,
and biotinylated anti-IgM, IgD, IgG, IgA, and IgE mAbs were
purchased from BD PharMingen (San Diego, CA). FITC-conjugated
anti-CD19, CD20, and anti-CD27 mAbs and PE-conjugated
anti-CD19 mAb were purchased from BD Biosciences (San Jose, CA).
IL-2 was purchased from Endogen (Woburn, MA). IL-10 was generously
provided by Dr. R. de Waal Malefyt (DNAX Research Institute, Palo Alto,
CA). The source of recombinant human CD40L was membranes prepared from
the Sf21 insect cell line infected with baculovirus vector
containing CD40L cDNA (generously provided by Dr. M. Kehry, Boehringer
Ingelheim, Ridgefield, CT) (18). CFSE was obtained from
Molecular Probes (Eugene, OR) and BrdU was from Sigma-Aldrich (St.
Louis, MO).
Cells
Normal human spleens were obtained from organ donors (Australian Red Cross Blood Service, Sydney, Australia). Mononuclear cells were prepared by slicing splenic tissue into small pieces and disrupting the capsule by forcing the tissue through a filter mesh. RBCs were lysed and the remaining cells were washed twice and cryopreserved in liquid nitrogen until required. Total B cells were isolated from mononuclear cells using the CD19 DYNAbead and DETACHABEAD system (Dynal Biotech, Oslo, Norway) (13, 19) according to the manufacturers instructions. The resulting cell population was >98% CD19+. Total B cells were then fractionated into naive (CD27-) and memory (CD27+) (7, 10) populations by incubating B cells with anti-CD27 mAb MACS beads and separating them on Mini or MidiMACS columns (Miltenyi Biotec, Bergisch Gladbach, Germany). Naive and memory B cells were also isolated by cell sorting using aFACStarPlus (BD Biosciences) by labeling the total B cell population with PE-conjugated anti-CD27 mAb and collecting CD27- and CD27+ B cells. IgM-expressing (nonswitched) and isotype-switched memory B cells were also isolated by cell sorting. Total B cells were labeled with PE-conjugated anti-CD27 mAb and a cocktail of biotinylated mAbs specific for IgG, IgA, and IgE (IgG/A/E) or IgM and IgD (IgM/D), followed by SA-TC (19). Gates were set to collect CD27+IgG/A/E- (i.e., IgM/D-expressing, nonswitched) memory B cells and CD27+IgM/D- (i.e., isotype-switched) memory B cells. The recovered B cell populations contained >98% of the respective subsets.
CFSE labeling
Purified human B cells were labeled with CFSE as previously described (13, 19, 20, 21). B cells were resuspended at 1 x 107/ml in PBS containing 0.1% BSA. CFSE, dissolved in DMSO, was added at a final concentration of 5 µM. The cells were vortexed for 10 s and then incubated at 37°C for 10 min. Labeled cells were then washed with cold PBS containing 0.1% BSA and resuspended in culture medium (see below; B cell cultures).
B cell cultures
CFSE-labeled naive and memory B cells (2 x 105/500 µl/well) were cultured in 48-well plates (BD Labware, Franklin Lakes, NJ) with recombinant human CD40L alone (at a predetermined optimal dilution of the membrane preparation; 1/250) or in the presence of IL-2 (50 U/ml) and/or IL-10 (100 U/ml) for different times. In some experiments, unlabeled B cells (4 x 105/ml) were cultured in flat-bottom 96-well plates (BD Labware) with CD40L, IL-2, and IL-10. Proliferation was assessed by pulsing the cultures with [3H]thymidine (ICN Pharmaceuticals, Irvine, CA) after various times of activation and harvesting 4 h later. Scintillation counting was performed on a Betaplate counter (Pharmacia-LKB, Uppsala, Sweden). All B cell cultures were performed in RPMI 1640 containing L-glutamine (Life Technologies, Grand Island, NY) and supplemented with 10% FCS (Life Technologies), 10 mM HEPES (pH 7.4; Sigma-Aldrich), 0.1 mM nonessential amino acid solution (Sigma-Aldrich), 1 mM sodium pyruvate (Life Technologies), 60 µg/ml penicillin, 100 µg/ml streptomycin, and 40 µg/ml apo-transferrin (Sigma-Aldrich). Cells were cultured at 37°C in a humidified atmosphere containing 5% CO2.
Determining time to first division
For analysis of time of entry into the first cell division,
naive and memory B cells (5 x 104/125
µl/well) were cultured in flat-bottom 96-well plates (BD Labware) in
the presence or absence of the mitotic inhibitor demecolcine
(Sigma-Aldrich) (22) plus human CD40L alone or in the
presence of IL-2 and IL-10. After various times, the cultures were
pulsed with [3H]thymidine and harvested 4
h later. Flow cytometric analysis of CFSE-labeled cells confirmed that
treatment with demecolcine completely inhibited all cell division (data
not shown). To determine the average time to first division
(ttfd), log-normal distributions were fitted to the
data with Prism software (Graphpad Software, San Diego, CA) using the
technique of least squares minimization. The equation fitted was as
follows: Y = Amplitude x (e
(-0.5 x
(ln(T/Center)/Width)2)) + background. The best
fit for the "center" parameter was taken as the average
ttfd, whereas the amplitude was assumed to be proportional
to the number of cells stimulated into division.
Immunofluorescent staining and BrdU analysis
Cultured naive and memory B cells were pulsed with 100 µg/ml BrdU for 6 h. Cells were then harvested from culture wells and nonspecific binding sites blocked by preincubating with normal mouse IgG (10 µg/ml). Cells were suspended in PBS containing 0.1% BSA and 0.1% sodium azide and fixed for 20 min with 2% paraformaldehyde (Sigma-Aldrich), diluted with an equal volume of Tween 20 (final concentration 0.1%; Sigma-Aldrich), and then incubated overnight. DNase I (Roche, Castle Hill, New South Wales, Australia; 50 µg/ml prepared in 50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, 100 µg/ml BSA) was added at 37°C for 30 min before incubating with PE-conjugated isotype control or anti-BrdU mAb on ice for 20 min. In some experiments, the expression of CD38 was determined by labeling cells with biotinylated anti-CD38 mAb before fixation and permeabilization, which was then detected with SA-TC. Cultures that had not been pulsed with BrdU were similarly harvested and treated to ascertain the background binding of the anti-BrdU mAb. Data were acquired on a FACScan flow cytometer using CellQuest software (BD Biosciences). Surface staining was measured on a logarithmic scale. Cells present in different divisions were characterized by "division slicing." Gates were drawn around each of the peaks present in histograms of CFSE-labeled B cells, representing cells in different divisions. The proportion of cells within each gate or the expression of BrdU by these cells was determined by backgating and analyzing the various divided populations, defined by CFSE dilution, using the analysis tools of CellQuest.
| Results |
|---|
|
|
|---|
Memory B cells were distinguished from naive B cells within the CD19+ population by expression of CD27 (7, 10). Naive (CD27-) B cells were uniformly IgM+IgDhigh and contained <2% IgG+ and IgA+ cells. In contrast, memory (CD27+) B cells were heterogeneous for isotype expression, containing IgM-only cells (Fig. 1 and Refs. 6 and 13) as well as isotype-switched B cells (Fig. 1).
|
Proliferation of human naive and memory B cells was initially
investigated by monitoring incorporation of
[3H]thymidine by purified B cell subsets
cultured for different periods of time with the T cell-derived stimuli
CD40L, IL-2, and IL-10. Uptake of [3H]thymidine
by memory B cells exceeded that by naive B cells at all culture times
examined (Fig. 2a).
Furthermore, initial incorporation of
[3H]thymidine by memory B cells appeared to
precede that by naive B cells by
2448 h (Fig. 2a).
Similar results were obtained when B cells were stimulated in vitro
with CD40L only (data not shown). Proliferation of naive and memory B
cells was then investigated in more detail using the division-tracking
dye CFSE (20, 21). This technique revealed that a greater
proportion of memory B cells than naive B cells entered division, as
evidenced by fewer undivided memory B cells and more memory B cells in
later divisions (compare Fig. 2, b and c). The
enhancement in proliferation of CD40L-stimulated memory B cells over
naive B cells was observed irrespective of the presence of exogenous
IL-10 alone or in combination with IL-2 (Fig. 2, b and
c). CFSE-labeled B cells were then cultured with CD40L alone
or with IL-10 or IL-2 plus IL-10 for up to 5 days and were harvested to
calculate the proportion of cells that had undergone one or more
divisions after different periods of in vitro stimulation. Naive B
cells remained undivided for
72 h (Fig. 2d). After this
time, a small proportion of CD40L-stimulated naive B cells entered
division, which then increased for the remainder of the culture period,
reaching a maximum of
20% of cells in culture. IL-10 increased the
proportion of dividing naive B cells at all time points examined to a
maximum of
65% after
100 h (Fig. 2d). In contrast to
naive B cells, divided cells were evident in cultures of memory B cells
by 72 h of in vitro stimulation (Fig. 2e), consistent
with the earlier incorporation of [3H]thymidine
by memory B cells compared with that of naive B cells (Fig. 2a). Not only did the percentage of divided memory B cells
detected rise sharply after 72 h for all culture conditions, but
the proportion of them observed at each harvest time exceeded that of
naive B cells. Thus, in the presence of CD40L, up to
60% of memory
B cells in culture had undergone division by 5 days, whereas adding
cytokines increased this figure to >90% (compare Fig. 2, d
and e). Notably, the percentage of divided naive B cells in
cultures stimulated with CD40L, IL-2, and IL-10 approximated that of
memory B cells stimulated with only CD40L (Fig. 2, d and
e), indicating increased sensitivity of memory B cells to
stimulation compared with naive B cells. IL-2 failed to increase the
proliferative response of naive B cells stimulated with CD40L and
IL-10, whereas proliferation of memory B cells was enhanced
(Fig. 2, be). Thus, memory B cells undergo
increased proliferation compared with naive B cells receiving identical
stimuli.
|
According to the data shown in Fig. 2, divided B cells
weredetectable in cultures of memory B cells earlier than in those
of naive B cells, suggesting that enhanced proliferation of memory B
cells may result from these cells entering division before naive B
cells. To measure their ttfd directly, naive and memory B
cells were stimulated with CD40L with or without cytokines in the
presence of the mitotic inhibitory drug demecolcine. This procedure
selectively measures time of entry of cells into their first S-phase
(22), as demecolcine blocks all subsequent rounds of cell
proliferation. Incorporation of [3H]thymidine
was monitored after different times of culture. Both B cell populations
exhibited a broad variation in time of entry into first division
(S-phase) after culture with either CD40L alone (Fig. 3a) or CD40L, IL-2, and IL-10
(Fig. 3b). Furthermore, irrespective of cell type or
stimulus, the time of entry conformed accurately to a log-normal
distribution, consistent with stochastic variability within the B cell
population (Fig. 3, a and b). The mean of the
fitted log-normal curve was taken as the mean ttfd for the B
cell populations. In the presence of CD40L alone, the mean
ttfd for naive and memory B cells was 85 and 57 h,
respectively (Fig. 3a; Table I). This is consistent with the times
when divided cells were first detected in cultures of CFSE-labeled
naive and memory B cells (see Fig. 2, d and e).
Not only did memory B cells enter division earlier than did naive B
cells, but differences in the amplitude of the curves suggest that a
greater number of memory B cells were being recruited into cell cycle
(Table I). Addition of IL-10 (with or without IL-2) reduced the
ttfd of naive B cells by
10 h and increased the number of
cells (i.e., amplitude of the curve) 5-fold (Fig. 3b;
compare donors 7 and 12* cultured with CD40L ± IL-2/IL-10 in
Table I). IL-10 alone (data not shown) or in combination with IL-2 had
little effect on ttfd of memory B cells and only increased
the cell number (i.e., amplitude of the curve) by a maximum of 2-fold,
compared with CD40L alone (Fig. 3, a and b; Table I). Although the ttfd of CD40L-stimulated naive B cells was
reduced by adding cytokines, memory B cells stimulated with CD40L,
IL-2, and IL-10 still entered division significantly earlier
(p < 0.01; Fig. 3b; Table I). By
using naive and memory B cells isolated from different donors, it was
clear that these results were highly reproducible (Table I).
|
|
|
The increased division of memory B cells compared with naive B cells may also be associated with an elevated rate of proliferation. That is, the time to traverse each division may be less for memory B cells than naive B cells, as observed recently for murine naive and memory CD8+ T cells (23). To assess this, cultures of activated naive and memory B cells were pulsed at different times with BrdU, and its incorporation after 6 h was determined as an indicator of division rate. This analysis indicated that the time when the greatest proportion of naive and memory B cells were incorporating BrdU, and therefore dividing, was 4 days and 3 days, respectively (Fig. 4, a and b). At later times, the proportion of BrdU+ naive and memory B cells declined (Fig. 4, a and b). Despite this difference, the frequency of naive and memory B cells incorporating BrdU was similar during and after the peak response. The analysis was extended by measuring incorporation of BrdU by cells in different divisions. Unlike murine T and B lymphocytes, which exhibit a consistent rate of proliferation across division (24, 25), the rate of BrdU uptake by human naive and memory B cells across different divisions was heterogeneous (Fig. 4, c and d). Thus, cells in later divisions were on average dividing faster. Overall, the rate of incorporation of BrdU per division for naive and memory B cells was comparable (Fig. 4, c and d). Investigating proliferation by this method further demonstrated that IL-10 altered the average division rate for both cell populations, whereas IL-2 further increased proliferation of memory B cells only (Figs. 4, ad).
|
After stimulation with CD40L, in the absence or presence of IL-10 and IL-2, memory B cells, but not naive B cells, yield a population of differentiated cells identified by expression of CD38 (Fig. 5a). This population of cells is enriched for Ig-secreting cells (51). Importantly, the appearance of these cells increases with cell division (Fig. 5a) and they acquire an accelerated rate of proliferation (51). To determine the contribution of differentiated CD38+ B cells to the proliferative response of activated memory B cells, the proliferative characteristics of CD38- B cell blasts and differentiated CD38+ B cells were examined in more detail by measuring incorporation of BrdU after a 6-h pulse. Although only a small proportion (<5%) of CD38+ B cells was generated after culture of memory B cells with CD40L alone, 2530% more of these cells incorporated BrdU than did CD38- B cells (Fig. 5b, top panel). Addition of IL-10 alone (Fig. 5b, middle panel) or in combination with IL-2 (Fig. 5b, bottom panel) to cultures of CD40L-stimulated memory B cells increased the proportion of CD38+ B cells, as well as the proportion of BrdU+ B cells within both CD38- and CD38+ populations. Despite this increase, a greater proportion of CD38+ B cells continued to incorporate BrdU than CD38- B cells in these cultures (Fig. 5b).
|
Differential expression of IL-2R components by naive and memory B cells
The data presented in the preceding sections demonstrated that
IL-2 selectively enhanced proliferation of memory B cells activated
with CD40L and IL-10, yet had no effect on naive B cells (Figs. 2 and 4). This may reflect differential expression of the IL-2R complex on
naive and memory B cells. To investigate this, expression of CD25 and
CD132, the
- and
-chains of the IL-2R complex, respectively, by
naive and memory B cells before and after culture was determined.
Before culture, CD25 was absent from naive B cells but was detected on
2550% of memory B cells (Fig. 6, top panel). Similarly, expression of CD132 was up to 4-fold
higher on memory B cells than on naive B cells (Fig. 6, top
panel). After culture with CD40L alone (Fig. 6, middle
panel) or in combination with IL-10 (Fig. 6, lower
panel), CD25 and CD132 expression was increased on both B cell
populations; however, expression remained higher on a greater
proportion of memory B cells compared with naive B cells (Fig. 6).
Thus, differential expression of the IL-2R complex may contribute to
the selective effect of IL-2 on memory B cell proliferation.
|
| Discussion |
|---|
|
|
|---|
Naive and memory B cells also showed differences in sensitivity to
cytokines. IL-10 significantly reduced the ttfd of naive B
cells. In contrast, the magnitude of the CD40L-mediated response of
memory B cells leading to initial entry into cell division was only
slightly affected by IL-10 (Fig. 3; Table I). Despite this enhancement
in the presence of IL-10, naive B cells were still considerably slower
than memory B cells to start dividing, and fewer naive B cells
underwent proliferation. Thus, memory B cells appear to be more
sensitive to stimuli and require less stimulation to initiate a maximal
response. This conclusion was further supported by the observation that
the proportion of naive B cells undergoing division in response to
stimulation with CD40L, IL-2, and IL-10 approximated that of memory B
cells stimulated with CD40L alone (Fig. 2, d and
e). Consequently, entry of naive B cells into their first
division may be subjected to increased layers of regulation compared
with memory B cells, which respond more rapidly and to a smaller number
of stimuli. This trend can explain previous findings demonstrating that
memory B cells have a lower threshold for activation than do naive B
cells, responding to reduced concentrations of specific Ag and T cell
help (27). Similarly, in vivo-activated B cells, which are
likely to contain a population of memory B cells, respond to
concentrations of CD40L below the threshold needed for stimulating
naive B cells (28). Moreover, IL-2 selectively increased
proliferation of memory, but not naive, B cells after culture with
CD40L and IL-10 (Figs. 2 and 4). Consistent with this, expression of
CD25 and CD132 was
2-fold greater on memory than on naive B cells,
and in vitro activation up-regulated these receptor components further
on memory than on naive B cells (Fig. 6). The synergistic effect of
IL-2 and IL-10 on growth and differentiation of human B cells has
previously been attributed to the ability of IL-10 to increase
expression of CD25 on CD40-activated B cells (29). Taken
with our results, the B cells observed in this previous study to
up-regulate CD25 were presumably memory B cells present in the
population of total tonsillar B cells used (29). Our
results predict that differentiation of naive B cells into memory B
cells in vivo will alter the proliferative behavior of the resulting
memory B cells in terms of time to enter division, magnitude of the
response, and the growth factors capable of affecting this response.
These novel growth characteristics acquired in vivo by memory B cells
provide an explanation for the more rapid Ab response that occurs after
re-exposure to an invading pathogen.
A recent study in a BCR transgenic model suggested the molecular determinant for enhanced secondary responses in vivo is the cytoplasmic domain of IgG expressed by isotype-switched memory B cells (17). The mechanism whereby Ag-specific signaling through a BCR comprising this motif enhanced the response of memory B cells was by reducing cell death, rather than increasing the number of cells recruited into the response or increasing the rate of cell division (17). Although these results appear to contrast with ours, we did observe that the proliferation rate of activated naive and memory B cells was comparable once the cells had commenced dividing (Fig. 4). In an attempt to resolve this issue, we conducted an experiment that cannot be performed in mice, due to lack of appropriate cell surface markers in which responses by naive (i.e., IgM+) and IgM-expressing memory B cells were compared. The data revealed that the ttfd of IgM-expressing memory B cells was comparable to switched memory B cells and significantly shorter than naive B cells (Fig. 3; Table II). Thus, factors other than, or in addition to, the cytoplasmic domain of switched Ig isotypes may account for differences in the magnitude of responses exhibited by naive and memory B cells. However, because the need for specific Ag was bypassed in our culture system by providing B cells directly with T cell help in the form of CD40L, the apparent discrepancies between the data for murine and human memory B cells may also be explained by involvement of the IgG cytoplasmic domain when B cells receive signals concomitantly via CD40 and the BCR.
Some of the characteristics identified here for human memory B cells
are similar to
IgMhighIgDlowCD21++CD23-
B cells present in the MZ of mouse spleen (16, 30, 31, 32, 33, 34).
These MZ B cells exhibited a greater degree of activation than did
naive B cells when proliferation, differentiation into Ig-secreting
cells, and intracellular signaling in response to LPS and BCR ligation
in vitro or Ag exposure in vivo were assessed (16, 30, 31, 32, 33). Notably, the differences we observed in CFSE profiles
between human naive and memory B cells (Fig. 2) were also observed for
murine naive follicular and MZ B cells stimulated with anti-CD40
mAb (16), suggesting that murine MZ B cells enter division
earlier than do follicular B cells. It has recently been demonstrated
that murine memory CD8+ T cells began dividing
15 h earlier than did naive CD8+ T cells in
vivo in response to the same immunizing Ag (23). Thus,
accelerated entry into division may represent a common mechanism for
elevated responses of memory lymphocytes belonging to B and T cell
lineages, as well as MZ B cells. Another mechanism by which human
memory and murine MZ B cells respond more rapidly than naive B cells
may involve differential expression of molecules involved in delivering
activating signals. Expression of IgM, CD19, CD21, CD40, costimulatory
molecules (CD80, CD86), and adhesion molecules is greater on memory and
MZ B cells compared with naive B cells (Fig. 1 and Refs. 10, 12, 13, 16, 31, 35). It has been found that coligating CD40 and
CD21 or surface Ig enhances B cell proliferation
(36, 37, 38), and interactions between B and T cells or
follicular dendritic cells via adhesion molecules promotes B cell
survival, activation, proliferation, and differentiation
(39, 40, 41, 42, 43). Similarly, costimulation of anti-CD3
mAb-activated human T cells with anti-CD28 mAb rapidly up-regulates
and sustains CD40L expression, which subsequently heightens B cell
responses (44, 45). Thus, after interactions with Ag,
cytokines, T cells, and dendritic cells within secondary lymphoid
tissues, the response time of human memory and murine MZ B cells may be
further reduced due to the potentially lower sensitivity of these cells
to signals delivered via coreceptors, as well as enhanced "help"
memory B cells may receive from costimulated T cells.
Naive and memory B cells differed in their ability to differentiate into CD38+ effector cells that proliferated at a rate exceeding that of CD38- memory B cells as well as naive B cells (Fig. 5). Importantly, the CD38+ B cell subset contained a population of Ig-secreting cells (51). These acquired differences suggest that distinct molecular mechanisms, such as the differential expression of transcription factors, regulate proliferation of CD38- and CD38+ B cell blasts generated from activated memory B cells in a manner analogous to regulating B cell differentiation (46, 47). Recent studies have indicated that bcl-6, a transcriptional repressor expressed by germinal center B cells, maintains B cells in a nondifferentiated state by suppressing expression of the transcription factor Blimp-1 (46). Similarly, differentiation of B cells into plasma cells is accompanied by increased expression of Blimp-1, which down-regulates the cell cycle regulatory protein c-myc, contributing to the reduced proliferation of plasma cells (47, 48). Curiously, plasma cells coexpressing bcl-6 and the proliferation Ag Ki-67 have been identified in situ (49, 50). Our data suggest that the rapidly proliferating CD38+ B cells generated from memory B cells in vitro may correspond to these plasmablasts observed in vivo. The sustained expression of bcl-6 in developing plasmablasts may delay the Blimp-1-mediated down-regulation of c-myc and thus facilitate the generation of large numbers of Ag-specific, Ig-secreting cells from proliferating precursors before their terminal differentiation into nondividing plasma cells (46). Thus, although Blimp-1 is expressed by plasmablasts, its effects may only manifest after this proliferative burst and subsequent down-regulation of bcl-6. In conclusion, human memory B cells possess intrinsic proliferative and differentiation characteristics over naive B cells that facilitate their early entry into cell division and differentiation into a rapidly dividing population of Ig-secreting cells. These characteristics, along with their unique positioning within Ag-draining sites of lymphoid tissue (1, 9, 10, 11), may contribute to the accelerated and efficient Ab response exhibited by memory B cells after secondary challenge by an invading pathogen.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Stuart G. Tangye, Centenary Institute of Cancer Medicine and Cell Biology, Locked Bag #6, Newtown 2042, New South Wales, Australia. E-mail address: s.tangye{at}centenary.usyd.edu.au ![]()
3 Current address: Walter & Eliza Hall Institute of Medical Research, Post Office, Royal Melbourne Hospital, Victoria 3050, Australia. ![]()
4 Abbreviations used in this paper: MZ, marginal zone; BCR, B cell receptor; CD40L, CD40 ligand; SA-TC, streptavidin conjugated to TriColor; BrdU, 5-bromo-2'-deoxyuridine; ttfd, time to first division. ![]()
Received for publication September 6, 2002. Accepted for publication November 5, 2002.
| References |
|---|
|
|
|---|
4
7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites. J. Leukocyte Biol. 68:807.Related articles in The JI:
This article has been cited by other articles:
![]() |
H. Schmidlin, S. A. Diehl, M. Nagasawa, F. A. Scheeren, R. Schotte, C. H. Uittenbogaart, H. Spits, and B. Blom Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression Blood, September 1, 2008; 112(5): 1804 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dussault, E. Ducas, C. Racine, A. Jacques, I. Pare, S. Cote, and S. Neron Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2 Int. Immunol., August 8, 2008; (2008) dxn090v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Avery, V. L. Bryant, C. S. Ma, R. de Waal Malefyt, and S. G. Tangye IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4 J. Immunol., August 1, 2008; 181(3): 1767 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Tomayko, S. M. Anderson, C. E. Brayton, S. Sadanand, N. C. Steinel, T. W. Behrens, and M. J. Shlomchik Systematic Comparison of Gene Expression between Murine Memory and Naive B Cells Demonstrates That Memory B Cells Have Unique Signaling Capabilities J. Immunol., July 1, 2008; 181(1): 27 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Rohner, M. D. Snape, D. F. Kelly, T. John, A. Morant, L.-M. Yu, A. Borkowski, F. Ceddia, R. Borrow, C.-A. Siegrist, et al. The Magnitude of the Antibody and Memory B Cell Responses during Priming with a Protein-Polysaccharide Conjugate Vaccine in Human Infants Is Associated with the Persistence of Antibody and the Intensity of Booster Response J. Immunol., February 15, 2008; 180(4): 2165 - 2173. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Bryant, C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. de Waal Malefyt, and S. G. Tangye Cytokine-Mediated Regulation of Human B Cell Differentiation into Ig-Secreting Cells: Predominant Role of IL-21 Produced by CXCR5+ T Follicular Helper Cells J. Immunol., December 15, 2007; 179(12): 8180 - 8190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Foote, B. J. Nonnecke, D. C. Beitz, and W. R. Waters Antigen-Specific B-Cell Responses by Neonatal Calves After Early Vaccination J Dairy Sci, November 1, 2007; 90(11): 5208 - 5217. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Anderson, M. M. Tomayko, A. Ahuja, A. M. Haberman, and M. J. Shlomchik New markers for murine memory B cells that define mutated and unmutated subsets J. Exp. Med., September 3, 2007; 204(9): 2103 - 2114. [Abstract] [Full Text] [PDF] |
||||
|
|